“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Stryker Corporation (NYSE:SYK), a leading player in the medical technology industry with a substantial market capitalization of $149 billion, has been making waves with its strong financial ...

Truist raised the firm’s price target on Stryker (SYK) to $413 from $409 and keeps a Hold rating on the shares. The company remains a top-tier ...

Lake Street analyst Brooks O’Neil notes that Stryker (SYK) announced a definitive agreement for the sale of its U.S. spinal implants business ...

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Reported net sales increased 10.7% ...

Shares of Stryker Corp. SYK slid 1.03% to $391.07 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.47% to 6,039.31 and Dow ...

Stryker beat Wall Street estimates for fourth-quarter profit and forecast 2025 earnings largely above expectations on Tuesday, fueled by strong demand for its medical and surgical devices.

MemorialCare Long Beach Medical Center is the first hospital in California to add Stryker's Q Guidance system with Spine Guidance software, according to a Jan.

Here are eight things for ASCs to know about the sale: 1. Stryker's U.S. spine segment will be sold to investment firm Viscogliosi Brothers. 2. That group will create VB Spine, which will be a ...

Stryker ( ($SYK) ) has shared an update. On January 28, 2025, Stryker announced the retirement of Glenn S. Boehnlein from his role as Vice ...